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ABSTRACT
Comparative genomic hybridization (CGH) micro-
arrays have been used to determine copy number
variations (CNVs) and their effects on complex
diseases. Detection of absolute CNVs independent
of genomic variants of an arbitrary reference sample
has been a critical issue in CGH array experiments.
Whole genome analysis using massively parallel
sequencing with multiple ultra-high resolution CGH
arrays provides an opportunity to catalog highly
accurate genomic variants of the reference DNA
(NA10851). Using information on variants, we de-
veloped a new method, the CGH array reference-
free algorithm (CARA), which can determine
reference-unbiased absolute CNVs from any CGH
array platform. The algorithm enables the removal
and rescue of false positive and false negative
CNVs, respectively, which appear due to the
effects of genomic variants of the reference
sample in raw CGH array experiments. We found
that the CARA remarkably enhanced the accuracy
of CGH array in determining absolute CNVs. Our
method thus provides a new approach to interpret
CGH array data for personalized medicine.
INTRODUCTION
Genomic variants, including single nucleotide polymorph-
isms (SNPs) and structural variations (SVs), have been
utilized to identify genetic factors underlying many
complex diseases. Copy number variations (CNVs) are
the most abundant form of SV (1). The effects of CNVs
on human complex diseases have been widely assessed
over the past few years, after the high-throughput detec-
tion of CNVs became technically feasible (2–7). The
recently constructed common ultra-high resolution CNV
maps in human populations are being widely used to study
both the distribution and impact of CNVs on complex
human traits, including complex diseases (8,9).
Comparative genomic hybridization (CGH) array tech-
nology has been widely used for genome-wide detection of
CNVs (1,5,6,8–10), followed more recently by a massively
parallel re-sequencing-based approach, including pair-end
read mapping (PEM) and read-depth (RD) analysis
(11–19). Although sequencing-based approaches offer
some advantages for detecting de novo CNVs as well as
accurately determining CNV breakpoints, there is a
growing need for standardization of these methods. In
particular, short reads from high or low GC genomic
regions and repetitive genomic regions, such as segmental
duplications and simple repeats, provide an unreliable RD
of sequence coverage (14,17). In addition, the PEM
method is inefﬁcient for detecting large CN gains and
small CN losses. To be more accurate, sequencing
methods also require comparison of multiple individual
genomes, which have yet to be standardized (18–20).
Due to its accuracy and cost-effectiveness, CGH arrays
have remained the most frequently used methods for
genotyping personal CNVs, both for association studies
and for developing personalized medicine.
The CGH array approach, however, depends heavily on
an arbitrary reference sample, severely limiting the utility
of this method. Since this method compares the amounts
of DNA from samples of interest (test samples) and a
reference sample hybridized to oligonucleotide probes,
any aberrancy in DNA quantity of the reference sample
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determining the absolute CNVs of the test samples. The
reference sample is not an ideal DNA, as it may include
thousands of genomic variants, resulting in misidentiﬁca-
tions and misinterpretations of test sample CNVs during
CGH array experiments (6). For example, a CN normal
region (copy number 2) in a test sample may be reported
as a gain or loss in CN, or as normal depending on the CN
of the reference sample (Supplementary Figure S1).
Likewise, CNVs of the test sample may be undetected
due to CNV of the reference sample. This dependency
on a reference sample may have been the main cause for
the low level of concordance between CNVs from CGH
arrays and massively parallel sequencing (11–13,17,18).
Although pooled DNA may resolve reference biases, it
may also decrease the power of CNV detection in highly
CN polymorphic regions (21). Alternatively, absolute
CN can be assessed using a clustering algorithm (8);
however, this method may not always be applicable
or accurate when CGH array experiments do not
include sufﬁcient number of DNA samples. Moreover,
CGH array data obtained by multiple platforms cannot
be clustered. Thus, to include CNV information in
personalized medicine, it is important to develop
new methods for accurately determining absolute
CNVs using CGH arrays independent of an arbitrary ref-
erence DNA.
DNA from a male of European ancestry, NA10851, has
been used as a reference for CGH array in most studies of
human CNVs (5,6,8–10,13,17,22), and many of the future
CGH array experiments will undoubtedly use the identical
reference sample. Hence, understanding CNV information
speciﬁc to NA10851 is critical for interpretation of CGH
array experiments. We recently reported absolute Asian
CNVs using preliminary CNV information from
NA10851 (9). Here we report the complete personal
CNVs of NA10851 by both CGH array and massively
parallel sequencing. In addition, we describe CARA algo-
rithm, which enables simple derivation of accurate
reference-independent CNV genotyping. This general al-
gorithm is compatible with any CGH array platform.
Finally, we report user-friendly software to implement
this algorithm.
MATERIALS AND METHODS
Whole genome sequencing
The cell-line of NA10851 was acquired from the Coriell
Cell Repository (http://ccr.coriell.org). Genomic DNA
was extracted from the cell line using standard protocols.
Libraries for massively parallel sequencing (Illumina
Genome Analyzer IIx) were constructed according to the
manufacturer’s standard protocol (Illumina, Inc., USA).
We constructed three different libraries, which were
designed to have inserts of 500bp between paired-end
reads. Paired-end sequencing was performed using three
read lengths, 2 36, 2 76 and 2 101bp. All reads were
aligned to the human reference genome (assembly build
36.3, hg18) using GSNAP alignment tool (17,23). A single
position was randomly determined when short reads had
multiple positions with identical highest alignment scores.
To identify SNPs and short indels of NA10851 from
sequencing data, we used our own scripts, which merge
read alignment results and extract SNPs and short-indels,
as described previously (17).
Using our own script, the RD of sequence coverage
was calculated for each base of the human reference
genome assembly build 36.3 (hg18). The effects of
GC contents on the RD of sequence coverage were
adjusted using a modiﬁcation of the described method
(18), in that we determined the relationship between
GC contents and RD of coverage in 100bp windows
and adjusted the single-base RDs according to this
relationship.
Ultra-high resolution CGH data included in this study
We analyzed ultra-high resolution CGH array data
previously reported from 73 individuals, which used
NA10851 as the reference sample (8,9). By pooling those
CNV segments, we obtained putative NA10851 CNV
information. Overall, the data included 43911 CNV
segments of 40 individuals (20 unrelated Europeans
and 20 unrelated West Africans) using the NimbleGen
42M-probe and 24194 ﬁltered CNV segments of
33 individuals (31 unrelated East Asians, 1 European and
1 West African) using the Agilent 24M-probe CGH array.
Identifying NA10851 CNV regions
Genome-wide CNVs of NA10851 were screened using
high-resolution CGH array data and conﬁrmed by RD
of massively parallel sequencing. We assumed that all
68105 CNV segments were NA10851 candidate CNV
regions. For each CNV segment, the deviation of RD
from the average was calculated using the equation
(RDratio ¼ RDNA10851, CNVsegment=RDNA10851, wholegenome,
RDNA10851, wholegenome =25.25  and 12.67  for auto-
somes and the chromosome X, respectively). Segments
with RD ratio  1.15 and  0.85 were considered normal
regions and removed (n=21479). The remaining redun-
dant CNV segments (n=46626) were collapsed into min-
imally redundant CNV elements (CNVEs) using the
criteria previously suggested [>50% reciprocal overlap
(9)]. Of a total of 6499 CNVEs, 3002 with only one
segment were considered false positives and removed.
To compare the RD of 3497 CNVEs with their ﬂanking
regions (deﬁned as four times lengths of CNV candidates
to upstream and downstream), we calculated the median
value and standard deviation (SD) of RD for CNV can-
didates and their ﬂanking regions. For CNVE size >1 Mb,
>100kb, >1kb and >100bp, we used window size of 1kb,
100bp, 50bp and 30bp, respectively. The deviation value
(Z) was calculated using the formula:
Z50ð30Þ ¼
medianRDCNVE   medianRD50ð30Þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SD 2
CNVE =NCNVE+SD 2
50ð30Þ =N50ð30Þ
q
             
             
where N is the number of windows for the regions. A
CNVE was selected when its Z50 and Z30 were  1.96
(level of signiﬁcance 0.05). Subsequent visual inspection
e190 Nucleic Acids Research, 2010,Vol.38, No. 20 PAGE 2 OF 11of the 2621 remaining CNVEs showed that they could be
categorized into four groups (see ‘Results’ section and
Figure 1c for more details of visual inspection):
(i) Apparent CNV: RD was sufﬁciently stable for
reliable CNV detection. In addition, RD of the can-
didate region was clearly higher or lower than those
of its ﬂanking regions.
(ii) Indistinct region: RD was stable, but the magnitude
of the RD difference between the candidate region
and its ﬂanking regions was minimal.
(iii) Indeterminable region: RD was highly unstable.
Most of the candidates within extreme segmental
duplication regions (Supplementary Table S4) were
categorized into this group.
(iv) Nested CNV: The candidate region was part of
another apparent CNV, which better represents
the CNV.
We ﬁnally selected 1309 CNVEs in Group 1 for
NA10851 ﬁltered CNV regions. CNVEs clearly shown to
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Figure 1. Detection of NA10851 CNVs using conjugative methods, massively parallel sequencing and ultra-high resolution CGH arrays.
(a) Distribution of RD of coverage of NA10851 sequencing for CNV segments identiﬁed from CGH arrays of 73 individuals. (b) Identifying
CNVs of NA10851 using RD of sequence coverage on putative regions determined by CGH arrays. (c) Examples of four categories of candidate
CNVs by visual inspection. Top row, Apparent CNV; second row, Indistinct region; third row, Indeterminable region due to extremely unstable RD;
fourth and bottom, Nested CNV, the CNV candidate in the bottom row is removed since it is included in the CNV illustrated in the fourth row.
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gous CN losses.
The genomic overlaps between the ﬁltered CNVs and
human genes as well as repetitive sequence (such as
segmental duplication and simple repeats) were
examined using information downloaded from UCSC
genome browser (http://genome.ucsc.edu). We used
refGene.txt (July 2009), genomicSuperDups.txt
(c)
Figure 1. Continued.
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human genes, segmental duplications and simple repeats,
respectively. When a CNV overlap  1bp of a genic
region, we considered it gene related. Likewise, CNVs
with >50% overlap by segmental duplication or simple
repeats were so categorized.
NA10851 genome browser and CARA software
We developed a genome browser for NA10851 showing
genome-wide RD information as well as ultra-high reso-
lution CGH array data (http://cara.gmi.ac.kr). All infor-
mation on genomic variations information as well as our
CARA software can be downloaded from this website.
CARA software was developed using a tool of
Microsoft Visual Studio .Net 2008. An importing
module of high-resolution CGH array data was imple-
mented using a Microsoft ‘mscorlib’ library, and CNV
data of NA10851 used in the adjusting module were de-
posited in an ASCII ﬂat ﬁle format in CARA software.
The efﬁciency of CARA in adjusting CNV regions and in
processing large amounts of data was conﬁrmed by simu-
lation using a set of Agilent 24M high resolution CGH
array data of AK1 (9).
Validation of the accuracy of CARA using AK1 data
We validated the accuracy of the CARA by showing its
improvement in the genome-wide concordance between
the RD of sequence coverage and CGH array data using
AK1 (9,17). The 24M probe CGH array data of AK1
was CNV segmented using the ADM2 algorithm with
Agilent Genomic Workbench Standard Edition 5.0.14 as
described previously (9). Absolute CNVs were obtained in
the same way after CARA was applied to the CGH array
data with a centralizing coefﬁcient  =0.7 (see ‘Results’
section for details). We used the ﬁltering criteria |log2ratio|
 0.5 and P-value 1 10
 22 to remove false positives.
The RD for each CNV segment was calculated using the
short-read data reported previously (17), and the concord-
ance was determined between its deviation from the RD of
its ﬂanking regions and the corresponding log2ratio from
CGH array data.
Comparison of CNVs between before and after
applying CARA
We compared relative and reference-independent CNV
sets of AK1. The CNV segments in each group that did
not overlap any of the other groups by 1bp overlap were
categorized as unique to that group. Overlapping ones
are further categorized as follows: when the magnitude
of overlapping length was <80% reciprocally, they were
classiﬁed as ‘size altered’; those with  80% reciprocal
overlap but a change in log2 ratio 0.3 were classiﬁed as
‘log2 ratio altered’; and those CNVs with  80% reciprocal
overlap but without a signiﬁcant change in log2 ratio
(<0.3) were categorized as ‘no change’.
RESULTS
Cataloging genome-wide NA10851 CNVs
We analyzed 84.9Gb of massively parallel sequencing
data from three paired-end libraries constructed from
the genomic DNA of NA10851 (Table 1). The short
reads were aligned to the reference human genome
assembly build 36.3 (hg18) using the GSNAP alignment
tool as described previously (17,23). Overall, we covered
25.01 times the haploid genome. In total, we identiﬁed
3683016 SNPs and 319174 short insertion deletion poly-
morphisms (Supplementary Tables S1–S3).
To use genome-wide RD information, we calibrated the
effect of GC contents on sequence coverage (14). The
genome-wide read depth of NA10851 is shown on the
genome browser on our website (http://cara.gmi.ac.kr).
CNV detection from RD data alone is not sufﬁciently
accurate, since the RD normally ﬂuctuates even without
CNV in the genomic region (17). In order to solve this
problem, we ﬁrst obtained putative NA10851 CNV
regions using multiple ultra-high resolution CGH arrays,
and subsequently conﬁrmed these regions using their RD.
We analyzed the 68105 CNV segments from 73 individ-
uals detected by two different kinds of ultra-high reso-
lution CGH array platforms that used NA10851 as a
reference (see ‘Materials and Methods’ section for
details) (8,9). The RD ratios of all the CNV segments
were analyzed to identify the CNVs on putative
NA10851 CNV regions (see ‘Materials and methods’
section for details). The distribution of RD ratios
showed three clear peaks, near 0, 0.5 and 1.0, equivalent
to 0, 1 and 2 CN regions, respectively, of NA10851
(Figure 1a). Some CNV segments showed RD ratio sig-
niﬁcantly >1.0, indicating CN gains in NA10851.
We removed the CNV segments corresponding to
the NA10851 CN normal regions by initial ﬁlter criteria
(segments with RD ratio  1.15 and  0.85 were removed;
see ‘Materials and Methods’ section ‘Identifying NA10851
CNV regions’ for more detailed method). Then we
collapsed the 46626 remaining segments into 6499 minim-
ally redundant CNVEs for the ﬁrst-ﬁltered NA10851
Table 1. Summary of massively parallel sequencing of NA10851
Library Read length Insert size Total reads Aligned reads Aligned bases Genome
covered
RD Total SNPs Total Indels
Library #1 2 36bp 500bp 557060528 499554933 35966395532
99.71% 25.01  3683016 319174
Library #2 2 76bp 500bp 159462248 125776263 19116529680
Library #3 2 101bp 500bp 101921217 81211013 16403136593
Overall – – 818443993 706542209 71486061805
RD: read-depth of sequence coverage.
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single segments (N=3002) were removed, since singletons
are likely not true NA10851 CNV regions, inasmuch as
CNV regions of the reference DNA cause the regions to
appear as frequent relative CNV regions in multiple inde-
pendent CGH array experiments (Figure 1b). Moreover,
false positive CNVs on CGH array were likely to be
detected as singletons among populations, since they
tended to be randomly distributed throughout the entire
genome and are therefore difﬁcult to overlap.
Next, the RDs of the 3497 remaining CNVEs were
systematically compared with the RDs of their 50 and
30 ﬂanking regions. This step identiﬁed 2621
suggestive CNVEs for the second-ﬁltered NA10851
CNV regions. Finally, the RDs of the 2621 CNVEs
with their ﬂanking regions were visually inspected, in
order to remove unreliable regions (Figure 1c; see
‘Materials and Methods’ section). Thus, of a total of
2621 CNV candidates, 599 were considered indistinct
and removed. We also excluded 328 candidates located
in 16 genomic regions where the RDs are highly ambigu-
ous due to extreme segmental duplications, making de-
terminations of CNs for NA10851 unreliable
(Supplementary Table S4). In addition, 385 nested
CNVs were removed. Finally, 1309 apparent CNVs and
their RD ratios, which would be inverted and used as
adjusting coefﬁcient in CARA, were determined (Figure
2a and b, Supplementary Tables S5 and S6,
Supplementary Figure S2; see ‘Materials and Methods’
section for details).
The total and median lengths of the NA10851 CNVs
were 23.34Mb and 2.7kb, respectively. CN loss was
observed in 1023 regions and CN gain in 286. Among
the 1023 losses, 178 were considered homozygous. CN
gains and losses showed different size distributions
(Figure 2b), consistent with our previous report (9). Of
the 1023 CN losses and 286 gains, 594 (58.0%) and 59
(20.6%), respectively, were not involved by segmental du-
plications or simple repeats (Figure 2c), indicating that
segmental duplications are more enriched in CN gains
than in losses.
CARA: algorithm for reference-independent CNV
detection
We developed CARA to detect of reference-independent
CNVs in CGH arrays (Supplementary Figure S3). Using
the RD ratios of NA10851 CNV regions, this algorithm
modiﬁes the signal intensity (SI) for the reference sample
(NA10851) and the log2 ratio of target probes within the
range of the 1309 NA10851 CNV regions (Figure 3).
These corrections thus normalize the biased-log2 ratio as
if the reference sample has normal CNs. Autosomes and
sex-chromosomes are analyzed independently, since the
median signal intensity for sex chromosomes is nearly
half that of autosomes. If an overlapping NA10851
CNV region is not a homozygous CN loss, we corrected
the SI for the reference sample using the adjusting coefﬁ-
cient ( ), where   ¼ medianRDNA10851, wholegenome=median
RDNA10851, CNVE (inverse of RD ratio). Then, the reference
SI for each probe is adjusted according to the simple
equation, SI0
ref, probe¼ SIref, probe  , where SIref,probe is
the signal intensity of each probe for the reference
sample. The SI0
ref, probe can be considered the signal
intensity for two (normal) CN state. Then the
reference-independent log2ratio for the probe is calculated
using the formula:
log2 ratio0 ¼ log2
SItest, probe
SI0
ref, probe
 !
¼ log2
SItest, probe
SIref, probe
  
  log2  
¼ log2 ratio0   log2  
where log2ratio0 is the unadjusted log2ratio for the probe.
For regions of homozygous loss, the above formula is
inapplicable, since in theory, SIref, probe=0 and  =inﬁn-
ity. We therefore utilized another strategy, by replacing
SIref,probe with the median SI of the reference sample on
the corresponding arrays (SI0
ref, probe¼ medianSIref, array).
To reduce the false positive rate due to the arbitrary re-
placement, the signal intensity of the test sample of the
corresponding probes was also modiﬁed using a
pre-determined centralizing coefﬁcient ( ): SI0
test, probe¼
medianSItest, array+   SItest, probe   medianSItest, array
  
. The
coefﬁcient   can range from 0 (most conservative central-
ization) to 1 (not at all conservative) according to the
researcher’s choice. This centralization method re-
ﬂects the characteristics of each probe by controlling the
magnitude of signal intensity deviation from the median
value in the test sample. Our validation sug-
gested that 0.7 was optimal value for   in our experi-
mental setting (Supplementary Figure S4). Then the
reference-independent log2ratio for the probe can be
calculated as:
log2 ratio0 ¼ log2
SI0
test, probe
SI0
ref, probe
  
¼ log2
medianSItest, array+   ðSItest, probe   medianSItest, arrayÞ
medianSIref, array
  
We developed and released the ﬁrst version of user-
friendly and freely available software implementing
CARA, which can be downloaded from the website
(http://cara.gmi.ac.kr). Data from Agilent (feature ex-
tracted data) or NimbleGen platforms (.pair ﬁles) can
be analyzed with the current version of CARA. In a
simulation, the time required to adjust a 24 1M
probes Agilent platform was  40min using 8GB of
main memory on an Intel(R) Core(TM)2 Duo CPU
E8500 3.16GHz machine.
Validation of the accuracy of CARA using
AK1 CGH array data
To validate its accuracy, we applied the CARA to the
previously reported 24M probe CGH array data for
AK1 genome (9,17). The relative and reference-
independent CNV sets (before and after CARA, respect-
ively) were compared with the RD of AK1 sequence
coverage. The total numbers of CNV segments found
were similar (Figure 4a; N=535 and 598, respectively),
but, their contents were quite different. When we
compared the two sets of CNV segments, we found that
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Figure 2. Personal CNVs of NA10851. (a) Personal CNV distribution throughout the entire genome. (b) Numbers and lengths of CN losses and CN
gains of NA10851. (c) Size distribution of 1309 NA10851 CNV regions. (d) Repetitive context of CN gains and losses.
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were considered CNVs of NA10851 instead of AK1. In
addition, 21.7% of the CNV segments showed changed in
their sizes as well as altered log2 ratios from the relative
set. Only 39.3% of the relative CNVs were not related to
the CNVs of NA10851, so that their log2 ratios and sizes
did not change markedly. After applying CARA, 280
CNVs were rescued; these were undetected in the relative
sets because both the test and reference samples have iden-
tical CNVs. As a result, the concordance rate between the
CGH array and RD was markedly enhanced from 49.7 to
88.8% (Figure 4a and c). To our knowledge, this is the
highest concordance rate between CGH array results and
massively parallel sequencing data.
DISCUSSION
We have shown here an accurate personal CNV map of
NA10851. This sample has been widely used as a reference
sample for CGH array experiments (10,21). The early
phases of CNV discovery studies have focused on
determining CN variable genomic regions among entire
human populations, for which detection of absolute
CNVs has not been critical. As high-resolution CGH
array platforms have become available, more precise
CNV maps of human populations have been generated
(4–6,8,9). To employ CNVs in personalized medicine, it
is imperative to identify personal CNVs accurately. The
accuracy of CGH arrays has been often compromised
because the effects of CNVs of the reference sample
were not removed, the ﬁnal results, therefore, have been
biased. Thus, it is critical to identify reference CNVs and
also develop a streamlined approach to remove their
inﬂuence from CGH arrays. We utilized a systematic
approach to identify CNVs of the common reference
sample by combining information from the personal
genome sequence obtained from massively parallel
sequencing data and ultra-high resolution CGH arrays
obtained from 73 individuals using the sample as a refer-
ence. Compared with the personal genomes ascertained by
a single technology, such as massively parallel sequencing
or CGH array only, the NA10851 genome revealed by a
combination of these methods allowed us to obtain the
most accurate estimates of personal CNVs to date.
The predominance of numbers of CN losses over gains
is in good agreement with previous reports (8,9). Although
we believe that this is the predominant characteristic
feature of human CNVs, some technical issues are worth
considering. Generally, CN losses are easier to identify
than CN gains, using both the hybridization and the RD
methods. Especially, high proportion of CN gains are
placed on duplicated genomic regions, therefore it is dif-
ﬁcult to design unique probes of good quality for CGH
array or to align short-reads in resequencing methods. In
addition, the numbers of copies of DNA segments in re-
petitive regions, such as microsatellites, vary almost con-
tinuously among human populations, making detection of
integer CN difﬁcult. Moreover, the insertion of DNA se-
quences, which are not found on the human reference
genome, cannot be detected using general CGH array.
Approaches that do not depend on the human reference
genome, such as de novo assembly are therefore needed to
identify all the CN gains and their exact integer CNs in a
personal genome.
NA10851 is the most widely employed individual
genome in CGH arrays. Therefore, information on its
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Figure 3. Flowchart showing the CARA for detection of reference-independent CNVs using CGH arrays.
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curately estimating CNVs and their utility in personalized
medicine. Most human genomic variations have been
analyzed, cataloged and annotated in public databases
based on the ‘Human Reference Genome’, which has
been sequenced and assembled by Human Genome
Project (24). CARA enables the determination of
personal CNVs based on the human reference genome
rather than on an arbitrary sample NA10851. The high
concordance rate after CARA between CGH array and
RD shows the utility of CARA for accurately identifying
personal CNVs. Using CARA, absolute CNVs from a
variety of DNA samples, including cancer cells and
mosaic samples, can be assessed only if NA10851 is used
as a reference for CGH arrays. A more accurate determin-
ation of the genomic variants of NA10851 can increase the
accuracy of adjustment from CARA. Therefore, it is
critical to collect and release information on the genomic
variants on NA10851, such as newly detected CNVs, or
more precise CNV breakpoints. In addition, further
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higher RD and more accurate RD ratio, will be also
valuable for ﬁner adjustment. We have opened the
database of NA10851 genomic variants on the website
(http://cara.gmi.ac.kr) and we have released all relevant
information, such as CNVs, SNPs, short-indels and RD
of NA10851. We hope to get new information from the
community. As the information is updated, new versions
of CARA will be released.
Along with CGH arrays, massively parallel sequencing
is a powerful tool for identifying CNVs. However, system-
atic differences in CNVs calls due to the use of an arbi-
trary reference sample in CGH arrays have interfered with
complete sample-matched CNV comparisons between the
two technologies (12,13,17–18). By correcting the demerits
of CGH arrays using CARA, we were able to obtain the
highest sample-matched concordance between the
technologies.
To assess the impact of human CNVs, integer CNs (e.g.
0, 1, 2, 3) of each segment should be genotyped. Although
CARA enables the detection of normal CN, as well as CN
gains and losses, integer CN cannot be assessed, especially
in CN gains. The methodology for accurately identifying
personal structural variations will be improved continu-
ously as new algorithms are developed by ultra-high-
resolution CGH arrays and massively parallel sequencing.
Ultimately, a rapid algorithm for detecting the integer CN
of genes will be developed by combining all the CNV data
available. These efforts will enable the identiﬁcation of
disease-related CNVs, as well as understanding their role
in the pathophysiology of complex human diseases.
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